VFA
Values First Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-5
| Closed | -$449 | – | 236 |
|
2024
Q4 | $449 | Sell |
5
-2,057
| -100% | -$185K | ﹤0.01% | 220 |
|
2024
Q3 | $204K | Sell |
2,062
-67
| -3% | -$6.62K | 0.11% | 145 |
|
2024
Q2 | $197K | Sell |
2,129
-53
| -2% | -$4.91K | 0.12% | 146 |
|
2024
Q1 | $207K | Sell |
2,182
-489
| -18% | -$46.4K | 0.12% | 149 |
|
2023
Q4 | $238K | Buy |
2,671
+845
| +46% | +$75.4K | 0.14% | 136 |
|
2023
Q3 | $133K | Sell |
1,826
-30
| -2% | -$2.19K | 0.09% | 145 |
|
2023
Q2 | $154K | Buy |
1,856
+30
| +2% | +$2.5K | 0.09% | 151 |
|
2023
Q1 | $139K | Sell |
1,826
-217
| -11% | -$16.5K | 0.09% | 154 |
|
2022
Q4 | $170K | Buy |
2,043
+257
| +14% | +$21.3K | 0.12% | 134 |
|
2022
Q3 | $142K | Buy |
1,786
+66
| +4% | +$5.25K | 0.1% | 138 |
|
2022
Q2 | $128K | Buy |
+1,720
| New | +$128K | 0.09% | 141 |
|